We envisage that ERG fusion-positive prostate cancer cells are susceptible to energy stress and the PGC1α-Sirt1 axis might provide survival benefits to tumors by activating antioxidant and metabolic functions of ERG fusion. The gene discussed is SIRT1; the disease is prostate carcinoma.